News
We also found that tumors release a protein called Activin-A, which acts on blood vessels to cause the leakiness and, ultimately, loss of blood vessels in the muscle. When we used a gene therapy to ...
Tumors can destroy the blood vessels of muscles even when the muscles are nowhere close to the tumor. That is the key finding of a new study that my ...
These findings highlight the dual roles of antioxidants in cancer. Their impact depends on cancer type, stage, and genetic ...
A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.
1d
Medical Device Network on MSNClearNote Health’s pancreatic cancer test secures UKCA markingThe test claims to analyse epigenomic and genomic data from circulating, cell-free DNA obtained from a simple blood draw.
Methylation changes in microbiome-derived cfRNA enable more accurate CRC diagnosis than traditional DNA or abundance-based ...
Lack of early detection: One risk factor is also the fact that there are no early detection methods for pancreatic cancer, unlike breast or colon cancer. Future research will focus on blood tests ...
Trump administration policy tug-of-war between big medical groups that want COVID vaccines back on CDC schedule for healthy ...
Teplizumab offers a completely different approach. Instead of simply replacing insulin, it targets the immune attack that causes type 1 diabetes.
Researchers from the University of British Columbia (UBC) have uncovered a direct connection between high insulin ...
There was a special delivery for cancer patients at St. Elizabeth Hospital on Monday afternoon thanks to a woman who has made ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results